Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen

被引:2
|
作者
Vokurka, Samuel [1 ]
Svoboda, Tomas [1 ]
Karas, Michal [1 ]
Koza, Vladimir [1 ]
Jindra, Pavel [1 ]
Kazakov, Dmitry [2 ]
Boudova, Ludmila [2 ]
机构
[1] Univ Hosp, Dept Hematooncol, Plzen 30460, Pilsen, Czech Republic
[2] Univ Hosp, Dept Pathol, Plzen 30460, Pilsen, Czech Republic
来源
MEDICAL SCIENCE MONITOR | 2011年 / 17卷 / 09期
关键词
graft-versus-host disease; melphalan; allogeneic transplantation; oral; BONE-MARROW; MELPHALAN; FLUDARABINE; RECIPIENTS;
D O I
10.12659/MSM.881933
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Oral graft-versus-host disease (GVHD) is a significant complication after allogeneic stem cell transplantation (SCT) and there is no consistent information about its characteristics in patients after reduced-intensity conditioning regimen FLU/MEL (fludarabine 12(1 mg/m(2) and melphalan 140mg/m(2)). Material/Methods: This was a single-centre prospective observational study of patients after allogeneic SCT with FLU/MEL conditioning performed during the period 1/2005-12/2007. Characteristics of oral GVHD were observed in 71 patients. The observation was discontinued due to death, donor lymphocyte infusion (DLI) or new chemotherapy administration. Results: In 10/2010, the median duration of the observation of the cohort of the patients was 13 (0.2-69) months, and 42 (35-69) months in the still-ongoing 20/71 (28%) patients. Oral acute GVHD had sporadic 7% incidence, whereas oral chronic GVHD was observed in 33% of patients and persisted with median duration of 188 (11-665) days. Clinical and histopathological features were similar in both acute and chronic oral GVHD and included mucosal lichenoid changes, erythema, ulcerations and pseudomembranes, satellite necrosis, apoptotic bodies and lichenoid interface inflammation. Conclusions: It is necessary to consider complex clinical symptomatology and pathological correlations when classifying the oral GVHD, because local oral symptoms and histopathological features in both acute and chronic oral GVHD forms can be similar. Even though the oral chronic GVHD was mild in the majority of patients, it can be considered as clinically significant due to its incidence, duration and symptomatology. The FLU/MEL conditioning regimen should not be considered as low-risk protocol in this context.
引用
收藏
页码:CR480 / CR484
页数:5
相关论文
共 50 条
  • [31] Magnetic resonance enterography for assessment of intestinal graft-versus-host disease after allogeneic stem cell transplantation
    Thorsten Derlin
    Azien Laqmani
    Simon Veldhoen
    Ivayla Apostolova
    Francis Ayuk
    Gerhard Adam
    Nicolaus Kröger
    Peter Bannas
    European Radiology, 2015, 25 : 1229 - 1237
  • [32] Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
    Torlen, Johan
    Gaballa, Ahmed
    Remberger, Mats
    Mork, Lisa-Mari
    Sundberg, Berit
    Mattsson, Jonas
    Uhlin, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (06) : 1260 - 1268
  • [33] Low incidence and severity of graft-versus-host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced-intensity conditioning
    Cantu-Rodriguez, Olga G.
    Gutierrez-Aguirre, Cesar H.
    Jaime-Perez, Jose C.
    Trevino-Montemayor, Oscar R.
    Martinez-Cabriales, Sylvia A.
    Gomez-Pena, Alvaro
    Lopez-Otero, Avril
    Ruiz-Delgado, Guillermo J.
    Gonzalez-Llano, Oscar
    Mancias-Guerra, Maria C.
    Tarin-Arzaga, Luz D. C.
    Rodriguez-Romo, Laura N.
    Ruiz-Argueelles, Guillermo J.
    Gomez-Almaguer, David
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (06) : 521 - 530
  • [34] Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation
    Ijaz, Awais
    Khan, Ali Younas
    Malik, Saad Ullah
    Faridi, Warda
    Fraz, Muhammad Asad
    Usman, Muhammad
    Tariq, Muhammad Junaid
    Durer, Seren
    Durer, Ceren
    Russ, Atlantis
    Parr, Nadia Nunes Cavalcante
    Baig, Zeeshan
    Sagar, F. N. U.
    Ali, Zeeshan
    McBride, Ali
    Anwer, Faiz
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 94 - 99
  • [35] The significance of oral labial biopsy in hepatic graft-versus-host disease diagnosis in patients following allogeneic hematopoietic stem cell transplantation - a preliminary report
    Prochorec-Sobieszek, Monika
    Nasilowska-Adamska, Barbara
    Szumera-Cieckiewicz, Anna
    Tomaszewska, Agnieszka
    Halaburda, Kazimierz
    Szczepinski, Andrzej
    Szymanska-Giemza, Olga
    Ziarkiewicz-Wroblewska, Bogna
    Marianska, Bozena
    ANNALS OF TRANSPLANTATION, 2012, 17 (03) : 85 - 92
  • [36] Ultrasonographic evaluation of gastrointestinal graft-versus-host disease after hematopoietic stem cell transplantation
    Nishida, Mutsumi
    Shigematsu, Akio
    Sato, Megumi
    Kudo, Yusuke
    Omotehara, Satomi
    Horie, Tatsunori
    Iwai, Takahito
    Endo, Tomoyuki
    Iguchi, Akihiro
    Shibuya, Hitoshi
    Hatanaka, Kanako
    Shimizu, Chikara
    Teshima, Takanori
    CLINICAL TRANSPLANTATION, 2015, 29 (08) : 697 - 704
  • [37] Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation
    Wolf, Dominik
    Wolf, Anna Maria
    Fong, Dominic
    Rumpold, Holger
    Strasak, Alexander
    Clausen, Johannes
    Nachbaur, David
    TRANSPLANTATION, 2007, 83 (08) : 1107 - 1113
  • [38] Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease
    Miller, Holly K.
    Braun, Thomas M.
    Stillwell, Terri
    Harris, Andrew C.
    Choi, Sung
    Connelly, James
    Couriel, Daniel
    Goldstein, Steven
    Kitko, Carrie L.
    Magenau, John
    Pawarode, Attaphol
    Reddy, Pavan
    Riwes, Mary
    Yanik, Gregory A.
    Levine, John E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : 522 - 528
  • [39] Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
    Li, Jian-Ming
    Giver, Cynthia R.
    Lu, Ying
    Hossain, Mohammad S.
    Akhtari, Mojtaba
    Waller, Edmund K.
    IMMUNOTHERAPY, 2009, 1 (04) : 599 - 621
  • [40] Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant
    Marini, Bernard L.
    Markstrom, Denise
    Frame, David
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (04) : 255 - 263